The Multifaceted Burden of Chronic GVHD

Curative therapies can leave a lasting burden on cancer patients. Survivorship issues are becoming a "pandemic of treatment success" and include not only short- and long-term treatment sideeffects, development of subsequent cancers, and psychosocial issues, but also a lasting financial toll. It is increasingly recognized that cancer survivorship is tightly associated with a decline in financial health and the unavoidable impact of high associated medical care costs extending beyond those accrued during the initial treatment.
Source: Biology of Blood and Marrow Transplantation - Category: Hematology Authors: Source Type: research